Synchron pauses trials of second-gen brain implant; not safety-related

Synchron has paused clinical trials of its second-generation brain-computer interface, with leadership stating the pause is not safety-related. The reason for the pause remains undisclosed, creating uncertainty about the device's development timeline. This matters as Synchron is a leading player in the BCI space, and any delay could affect competitive dynamics with rivals like Neuralink.

AI disclosure: Model-written summary of the source, not a verified fact. Check the sources. How Mosaic works